Get started
Author

Yunqi Yu-Liu

Observed names: Y. Liu, Yunqi Yu, Yunqi Yu Liu
ORCID: 0009-0003-3148-5530
Observed ORCID: 0009-0003-3148-5530
OpenAlex ID: A5116077325
Prevalence of invasive fungal infection in critically Ill patients: a systematic review and meta-analysis
2025 · Mauricio Trelles, José Murillo, et al. · BMC Infectious Diseases · 24
PDF
Mortality in Cancer Patients with Septic Shock in Intensive Care: Systematic Review and Meta-Analysis
2025 · María Fernanda García-Aguilera, Yunqi Yu-Liu, et al. · Journal of Intensive Care Medicine · 10
Microbiological characterization of bacteremia in patients with chemotherapy-induced febrile neutropenia: systematic review and meta-analysis
2025 · Alvarez Franklin Correa, Paola Guasti, et al. · Therapeutic Advances in Infectious Disease · 3
Evaluation of prognostic factors for mortality in cancer patients with sepsis in the intensive care unit: systematic review protocol
2025 · María Fernanda García-Aguilera, Nayely García-Méndez, et al. · Critical Care Science · 1
PDF
Comparison of Arterial Access Sites in an Oncologic ICU: Is Brachial Artery Catheterization a Safe Alternative?
2026 · Luis Unigarro, Emérita Basantes, et al. · Journal of Intensive Care Medicine
Capillary refill time as a predictor of mortality in cancer patients with sepsis-associated circulatory dysfunction: A prospective cohort study
2026 · María Fernanda García-Aguilera, Glenn Hernández, et al. · Acta Colombiana de Cuidado Intensivo
Survival and socioeconomic factors in patients with cervical cancer undergoing palliative care: a retrospective cohort study
2026 · Carmen Jessenia Apolo, Sara Valeria Almeida, et al. · Frontiers in Cancer Control and Society
PDF
Análisis de las Preferencias Alimentarias en Pacientes Oncológicos en Tratamiento con Quimioterapia en el Hospital Oncológico de Solca Quito – Ecuador
2025 · María Fernanda García Aguilera, Katherine Taipe, et al. · Revista Ecuatoriana de Ciencia Tecnología e Innovación en Salud Pública
PDF
P590: Preliminary Safety and Efficacy of Bgb-11417, a Potent and Selective B-cell Lymphoma 2 (bcl2) Inhibitor, in Patients (pts) With Acute Myeloid Leukemia (aml)
2022 · J. Shortt, S. Y. Tan, et al. · HemaSphere
Works count: 9
Citation count: 38
H-index: 3
I10-index: 2
Year
Topic
Type